• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 84-98 of 6,889 results

No. 82 ECF FILER: ENTRY OF APPEARANCE from W. Gordon Dobie on behalf of Petitioner(s) Ascend Laboratories, ...

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 82 (3rd Cir. Mar. 7, 2024)
Please the names of all parties represented, using additional sheet(s) if necessary: Ascend Laboratories, LLC Indicate the party’s role IN THIS COURT (check only one): ✔ ____ Petitioner(s) ____ Appellant(s) ____ Intervenor(s) ____ Respondent(s) ____ Appellee(s) W. Gordon Dobie (Type or Print) Counse’s Name ________________________________________________________________ ____ Mr. ____ Ms. ____ Mrs. ____ Miss ____ Mx.
Notices generated from the Court’s ECF system will be sent to both the primary e-mail and additional e-mail addresses.
You are limited to 3 additional e-mail addresses.
A non-government attorney who is not currently in active status will be required to file the Attorney Admission Renewal /Adjustment of Status Form in order to proceed with the case.
Bar admission is waived for Federal and Virgin Island government attorneys.
cite Cite Document
Analyze

No. 88 ECF FILER: DISCLOSURE STATEMENT on behalf of Respondent Breckenridge Pharmaceutical Inc

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 88 (3rd Cir. Mar. 7, 2024)
Log in to see more
cite Cite Document
Analyze

No. 87 ECF FILER: ENTRY OF APPEARANCE from Donald W. Hawthorne on behalf of Petitioner(s) Breckenridge ...

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 87 (3rd Cir. Mar. 7, 2024)
Log in to see more
cite Cite Document
Analyze

No. 85 ECF FILER: ENTRY OF APPEARANCE from Michael J. Hartman on behalf of Petitioner(s) Amneal Pharmaceuticals, ...

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 85 (3rd Cir. Mar. 7, 2024)
Log in to see more
cite Cite Document
Analyze

No. 84 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioners Amneal Pharmaceuticals Inc and Amneal ...

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 84 (3rd Cir. Mar. 7, 2024)
Log in to see more
cite Cite Document
Analyze

No. 83

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 83 (3rd Cir. Mar. 7, 2024)

cite Cite Document
Analyze

No. 80

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 80 (3rd Cir. Mar. 6, 2024)

cite Cite Document
Analyze

No. 81

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 81 (3rd Cir. Mar. 6, 2024)

cite Cite Document
Analyze

No. 76

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 76 (3rd Cir. Mar. 6, 2024)

cite Cite Document
Analyze

No. 79

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 79 (3rd Cir. Mar. 6, 2024)

cite Cite Document
Analyze

No. 77

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 77 (3rd Cir. Mar. 6, 2024)

cite Cite Document
Analyze

No. 78

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 78 (3rd Cir. Mar. 6, 2024)

cite Cite Document
Analyze

No. 69

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 69 (3rd Cir. Mar. 5, 2024)

cite Cite Document
Analyze

No. 73

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 73 (3rd Cir. Mar. 5, 2024)

cite Cite Document
Analyze

No. 74

Document In re: Actavis Holdco U.S.., Inc., et al, 24-1295, No. 74 (3rd Cir. Mar. 5, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 ... >>